Internal Server Error

New Iridium - About the company

New Iridium is a seed company based in Boulder (United States), founded in 2016 by Chern-Hooi Lim, Brent Cutcliffe and Garrett Miyake. It operates as a Manufacturer of phenoxazine and dihydrophenazine. New Iridium has raised $2.65M in funding from Radicle and CIRI Ventures. The company has 233 active competitors, including 23 funded and 30 that have exited. Its top competitors include companies like Sai Life Sciences, Liverpool ChiroChem and NFIL.

Company Details

Social
X
Key Metrics
Founded Year
2016
Location
Boulder, United States
Stage
Seed
Total Funding
$2.65M in 6 rounds
Latest Funding Round
Investors
Ranked
Employee Count
8 as on Mar 31, 2026
Similar Companies
Sign up to download New Iridium's company profile

New Iridium's funding and investors

New Iridium has raised a total funding of $2.65M over 6 rounds. Its first funding round was on Feb 05, 2019. Its latest funding round was a Seed round on Jun 11, 2025 for $*****. 4 investors participated in its latest round. New Iridium has 8 institutional investors.

Here is the list of recent funding rounds of New Iridium:lockFilter this list
Date of Funding
Funding Amount
Round Name
Post-Money Valuation
Revenue Multiple
Lead Investors
Other Investors
Jun 11, 2025
5710714
Seed
7335870
1150044
2118945
3881434
Jul 22, 2024
6233027
Grant (prize money)
3188539
9584651
8811511
Jun 29, 2023
3191063
Grant (prize money)
7039572
8698570
6800836
lockAccess funding benchmarks and valuations. Sign up today!

New Iridium's founders and board of directors

Founder? Claim Profile
The founders of New Iridium are Chern-Hooi Lim, Brent Cutcliffe and Garrett Miyake. Chern-Hooi Lim is the CEO of New Iridium.
Here are the details of New Iridium's key team members:

New Iridium's employee count trend

New Iridium has 8 employees as of Mar 26. Here is New Iridium's employee count trend over the years:
Employee count trend for New Iridium
lockUncover New Iridium's growth story! Sign up today!
chrome_extension_cta_illustration
Access Tracxn on any website
Our Google Chrome extension lets you view company details while browsing their websites
Install Tracxn Extension

New Iridium's Competitors and alternates

Top competitors of New Iridium include Sai Life Sciences, Liverpool ChiroChem and NFIL. Here is the list of Top 10 competitors of New Iridium, ranked by Tracxn score:
Rank
Company Details
Short Description
Total Funding
Investors
Tracxn Score
1st
Logo for Sai Life Sciences
Sai Life Sciences
1999, Hyderabad (India), Public
Provider of drug discovery, developing, and manufacturing of complex small molecules
$108M
66/100
2nd
Logo for Liverpool ChiroChem
Liverpool ChiroChem
2014, Liverpool (United Kingdom), Acquired
Small organic molecule supplier for biotech/pharmaceutical R&D
$11.1M
51/100
3rd
Logo for NFIL
NFIL
1967, Mumbai (India), Public
CRAMS company specialising in the custom chemical synthesis and manufacturing of fluorinated compounds
-
-
51/100
4th
Logo for GL Chemtec International
GL Chemtec International
2002, Oakville (Canada), Acquired
Discovery stage CRO specializing in custom synthesis of fine chemicals and intermediates
-
-
51/100
5th
Logo for Bioduro
Bioduro
2005, San Diego (United States), Acquired
Global CRDMO providing integrated drug discovery, development, and manufacturing services
-
49/100
6th
Logo for IRBM
IRBM
2010, Pomezia (Italy), Funding Raised
Integrated drug discovery and preclinical development service provider
-
48/100
7th
Logo for Medicilon
Medicilon
2004, Pudong (China), Funding Raised
Integrated drug discovery and preclinical development services
-
48/100
8th
Logo for ChemLex
ChemLex
Shanghai (China), Series B
Provider of consulting services in the field of chemical research and development through artificial intelligence chemical synthesis
$71M
46/100
9th
Logo for New Iridium
New Iridium
2016, Boulder (United States), Seed
Manufacturer of phenoxazine and dihydrophenazine
$2.65M
45/100
10th
Logo for Alzheimer's Drug Discovery
Alzheimer's Drug Discovery
1998, New York City (United States), Funding Raised
Foundation aims to discover drugs to prevent, treat, and cure alzheimer's disease
-
 
45/100
lockGet insights and benchmarks for competitors of 2M+ companies! Sign up today!
Looking for more details on New Iridium's competitors? Click here to see the top ones

New Iridium's Investments and acquisitions

New Iridium has made no investments or acquisitions yet.

News related to New Iridium

Media has covered New Iridium for 1 event in last 1 year.
lockGet curated news about company updates, funding rounds, M&A deals and others. Sign up today!

FAQs about New Iridium

Explore our recently published companies
Tracxn powers 1,000+ customers across 30+ countries
Accel PartnersPartechIN-Q-TEL - USFujitsuTenityStanford